|
|
|
Volumn 10, Issue 9, 1997, Pages 99-107
|
|
A cost-effectiveness analysis of breath-actuated metered-dose inhalers.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
ETHANOLAMINE DERIVATIVE;
PIRBUTEROL;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
ASTHMA;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
ECONOMICS;
FEMALE;
HEALTH CARE COST;
HEALTH INSURANCE;
HUMAN;
INHALATIONAL DRUG ADMINISTRATION;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
NEBULIZER;
RANDOMIZED CONTROLLED TRIAL;
STANDARD;
TREATMENT OUTCOME;
UNITED STATES;
ADMINISTRATION, INHALATION;
ADOLESCENT;
ADRENERGIC BETA-AGONISTS;
ADULT;
AGED;
ASTHMA;
CHILD;
COST-BENEFIT ANALYSIS;
ETHANOLAMINES;
FEMALE;
HEALTH CARE COSTS;
HUMANS;
MALE;
MANAGED CARE PROGRAMS;
MIDDLE AGED;
NEBULIZERS AND VAPORIZERS;
TREATMENT OUTCOME;
UNITED STATES;
|
|
EID: 0031216132
PISSN: 10965645
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (10)
|
|
References (0)
|
